General Information of the Compound
Compound ID |
CP0116773
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-{5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl}benzonitrile
Show/Hide
|
||||||||||||||||||
Synonyms |
102676-47-1
4-{5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl}benzonitrile
5-p-cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine
Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-
Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-
CGS-16949A
CHEMBL9298
FADROZOLE
Fadrozol
Fadrozol [INN-Spanish]
Fadrozole (INN)
Fadrozole [INN]
Fadrozolum
Fadrozolum [INN-Latin]
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C14H13N3
|
||||||||||||||||||
Molecular Weight |
223.279
|
||||||||||||||||||
Canonical SMILES |
N#Cc1ccc(cc1)C1CCCc2cncn12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2
Show/Hide
|
||||||||||||||||||
InChIKey |
CLPFFLWZZBQMAO-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03119, Cytochrome P450 11B1, mitochondrial
Protein ID: PT03120, Cytochrome P450 11B2, mitochondrial
Clinical Information about the Compound